Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Cash & Equivalents (2016 - 2025)

Anterix's Cash & Equivalents history spans 13 years, with the latest figure at $29.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 2.56% year-over-year to $29.5 million; the TTM value through Dec 2025 reached $29.5 million, up 2.56%, while the annual FY2025 figure was $47.4 million, 21.8% down from the prior year.
  • Cash & Equivalents reached $29.5 million in Q4 2025 per ATEX's latest filing, down from $39.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $127.8 million in Q4 2021 to a low of $28.8 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $64.9 million, with a median of $54.6 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: plummeted 66.42% in 2023, then surged 78.12% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $127.8 million in 2021, then tumbled by 54.99% to $57.5 million in 2022, then increased by 7.86% to $62.0 million in 2023, then plummeted by 53.58% to $28.8 million in 2024, then grew by 2.56% to $29.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Cash & Equivalents are $29.5 million (Q4 2025), $39.1 million (Q3 2025), and $41.4 million (Q2 2025).